Javascript must be enabled to continue!
Integrative Oncology: An Overview
View through CrossRef
Integrative oncology, the diagnosis-specific field of integrative medicine, addresses symptom control with nonpharmacologic therapies. Known commonly as “complementary therapies” these are evidence-based adjuncts to mainstream care that effectively control physical and emotional symptoms, enhance physical and emotional strength, and provide patients with skills enabling them to help themselves throughout and following mainstream cancer treatment. Integrative or complementary therapies are rational and noninvasive. They have been subjected to study to determine their value, to document the problems they ameliorate, and to define the circumstances under which such therapies are beneficial. Conversely, “alternative” therapies typically are promoted literally as such; as actual antitumor treatments. They lack biologic plausibility and scientific evidence of safety and efficacy. Many are outright fraudulent. Conflating these two very different categories by use of the convenient acronym “CAM,” for “complementary and alternative therapies,” confuses the issue and does a substantial disservice to patients and medical professionals. Complementary and integrative modalities have demonstrated safety value and benefits. If the same were true for “alternatives,” they would not be “alternatives.” Rather, they would become part of mainstream cancer care. This manuscript explores the medical and sociocultural context of interest in integrative oncology as well as in “alternative” therapies, reviews commonly-asked patient questions, summarizes research results in both categories, and offers recommendations to help guide patients and family members through what is often a difficult maze. Combining complementary therapies with mainstream oncology care to address patients' physical, psychologic and spiritual needs constitutes the practice of integrative oncology. By recommending nonpharmacologic modalities that reduce symptom burden and improve quality of life, physicians also enable patients to play a role in their care. Critical for most patients, this also improves the physician-patient relationship, the quality of cancer care, and the well-being of patients and their families.
American Society of Clinical Oncology (ASCO)
Title: Integrative Oncology: An Overview
Description:
Integrative oncology, the diagnosis-specific field of integrative medicine, addresses symptom control with nonpharmacologic therapies.
Known commonly as “complementary therapies” these are evidence-based adjuncts to mainstream care that effectively control physical and emotional symptoms, enhance physical and emotional strength, and provide patients with skills enabling them to help themselves throughout and following mainstream cancer treatment.
Integrative or complementary therapies are rational and noninvasive.
They have been subjected to study to determine their value, to document the problems they ameliorate, and to define the circumstances under which such therapies are beneficial.
Conversely, “alternative” therapies typically are promoted literally as such; as actual antitumor treatments.
They lack biologic plausibility and scientific evidence of safety and efficacy.
Many are outright fraudulent.
Conflating these two very different categories by use of the convenient acronym “CAM,” for “complementary and alternative therapies,” confuses the issue and does a substantial disservice to patients and medical professionals.
Complementary and integrative modalities have demonstrated safety value and benefits.
If the same were true for “alternatives,” they would not be “alternatives.
” Rather, they would become part of mainstream cancer care.
This manuscript explores the medical and sociocultural context of interest in integrative oncology as well as in “alternative” therapies, reviews commonly-asked patient questions, summarizes research results in both categories, and offers recommendations to help guide patients and family members through what is often a difficult maze.
Combining complementary therapies with mainstream oncology care to address patients' physical, psychologic and spiritual needs constitutes the practice of integrative oncology.
By recommending nonpharmacologic modalities that reduce symptom burden and improve quality of life, physicians also enable patients to play a role in their care.
Critical for most patients, this also improves the physician-patient relationship, the quality of cancer care, and the well-being of patients and their families.
Related Results
STRATEGIC PLANNING FOR THE CORPORATE ENTERPRISE'S INTEGRATIVE DEVELOPMENT
STRATEGIC PLANNING FOR THE CORPORATE ENTERPRISE'S INTEGRATIVE DEVELOPMENT
This article is dedicated to the systematization of theoretical positions and the development of approaches concerning the strategic planning of integrative development for corpora...
Global Oncology Research and Training Collaborations Led by the National Cancer Institute (NCI)–Designated Cancer Centers: Results From the 2018 NCI/ASCO Global Oncology Survey of NCI-Designated Cancer Centers
Global Oncology Research and Training Collaborations Led by the National Cancer Institute (NCI)–Designated Cancer Centers: Results From the 2018 NCI/ASCO Global Oncology Survey of NCI-Designated Cancer Centers
PURPOSE The National Cancer Institute (NCI)–Designated Cancer Centers (NDCCs) are active in global oncology research and training, leading collaborations that contribute to the evi...
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
12063 Background: For patients with metastatic cancer, a key aspect of interdisciplinary care has involved the overall prognosis provided by Medical Oncology, which often dictates...
National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association (HOPA) survey.
National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association (HOPA) survey.
e13609 Background: Drug shortages are a clear and growing challenge. Prominent shortages included oncology medications and supportive care products essential for the care of cance...
Exploring the role of professional cancer societies in spreading awareness about oncology to undergraduate medical students: Experiences from Tamil Nadu, India.
Exploring the role of professional cancer societies in spreading awareness about oncology to undergraduate medical students: Experiences from Tamil Nadu, India.
e21013
Background:
Medical students in India are not formally exposed to evidence based, multi-disciplinary oncology care in their und...
SOLVING SCHOOL PROBLEMS OF INTEGRATIVE CONTENT: MATHEMATICS AND ECONOMICS
SOLVING SCHOOL PROBLEMS OF INTEGRATIVE CONTENT: MATHEMATICS AND ECONOMICS
The article is dedicated to the disclosure of the peculiarities of the formation of the skills of high school students to solve and investigate problems of integrative content offe...
Exploring the Impact of Resilience on Professional Quality of Life Among Oncology Nurses
Exploring the Impact of Resilience on Professional Quality of Life Among Oncology Nurses
Background:
Oncology nursing is recognized as a highly demanding field due to prolonged exposure to patient suffering, which can impact the professional quality...
Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population
Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population
Abstract
Background
The inverse log-linear relationship between Thyroid-stimulating hormone (TSH) and free thyroxine (FT4) is well established and reliably used for evalua...

